MIRA INFORM REPORT

 

Report Date :

24.03.2011

 

IDENTIFICATION DETAILS

 

Name :

RELISYS MEDICAL DEVICES LIMITED

 

 

Formerly Known As :

Care Polymed Private Limited

 

 

Registered Office :

SY No.312, Pocharam Road, Mangalapally Village, Ibrahimpatnam, Andhra Pradesh – 501510

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

13.10.1997

 

 

Com. Reg. No.:

01-028153

 

 

CIN No.:

[Company Identification No.]

U85101AP1997PLC028153

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDC00695C

 

 

PAN No.:

[Permanent Account No.]

AABCC5660L

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Innovation Driven Device

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (30)

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

Maximum Credit Limit :

USD 1072000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. Profitability of the company appears to be low. However, trade relations are reported as fair. Business is active. Payments are reported to be slow.

 

The company can be considered for business dealings with some caution

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – April 1, 2010

                                                

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

LOCATIONS

 

Registered Office :

SY No.312, Pocharam Road, Mangalapally Village, Ibrahimpatnam, Andhra Pradesh – 501510, India

E-Mail :

badari@relisysmedical.com

Website :

http://www.relisysmedicaldevices.com

 

 

Marketing Office :

Ground Floor, Plot NO. 82, Road No.6, Arunidaya Nagar, Nagole, Hyderabad – 500068, Andhra Pradesh, India

Tel. No.:

91-40-23493311

Fax No.:

91-40-24222206

E-Mail :

info@relisysmedical.com

sales@relisysmedical.com

 

 

DIRECTORS

 

As on 30.09.2010

 

Name :

Mr. Nagarada Gadde Badari Narayan

Designation :

Managing Director

Address :

2-2-647/85/A, 3rd Street, Sarada Nagar, Bagh Amberpet, Hyderabad, Andhra Pradesh

Date of Appointment :

01.08.2003

DIN :

00569510

 

 

Name :

Mr. Nallamala Krishna Reddy

Designation :

Director

Address :

H. No.2/99/E, Road No.2, Kakatiya Nagar, Habsiguda, Secunderabad, Andhra Pradesh

Date of Appointment :

01.08.2003

DIN :

00910584

 

 

Name :

Mr. Mohan Kallepalli

Designation :

Director

Address :

3-4-615/507, Lingampally, Ward-3, Circle-IV, Hyderabad – 500019, Andhra Pradesh

Date of Birth/Age :

20.07.1957

Date of Appointment :

07.12.2007

DIN :

01949591

 

 

Name :

Mr. Nalam Ramakrishna Rao

Designation :

Whole-time Director

Address :

Flat No.201, Brindavan, H. No.2-2-1109/1, Bagh Amberpet, Hyderabad - 500013

Date of Birth/Age :

15.06.1943

Date of Appointment :

24.01.2004

DIN :

02019776

 

 

Name :

Gadiraju Venkata Viswanadha Sarma

Designation :

Director

Address :

D-307, Hindustan CIBA Gaigy Research Centre, Goregaon, Mumbai – 400063, Maharashtra

Date of Birth/Age :

17.10.1946

Date of Appointment :

12.07.2008

DIN :

02267968

 

 

Name :

Mr. Bhagavatula Kutumba Srinivasa Sastry

Designation :

Director

Address :

304, HImsiva Apartments, Shivram Road, Amberpet – 500013, Andhra Pradesh

Date of Birth/Age :

22.06.1961

Date of Appointment :

02.09.2006

DIN :

02382879

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2010

 

Names of Shareholders

 

No. of Shares

Dr. D. Soma Raju

 

444500

Dr. D.N. Kumar

 

166667

Dr. P. Raghava Raju

 

154167

Dr/ Sunil K. KApoor

 

98125

Dr. B.K.S. Sastry

 

141904

Dr. N. Krishna Reddy

 

628840

A.C.A. Private Limited

 

537760

Sri. Kalindhi Narayan

 

434465

Sri N.G. Badari Narayan

 

701100

LAksmi Kanth Prabhala

 

60164

Ramkrishan Neravelta

 

53077

Mr. Ramesh USA

 

100000

Pranaya Realtors Inc, USA

 

72307

Dr. N Ramakrishna Rao

 

185884

Mr. N. Rajendra

 

91667

Mr. Kishore Kondapi

 

148151

Niamatali Habibool

 

63018

Mr. Yamani Kumar – USA

 

133333

B. China Ram Mohan Raju

 

66667

G2 Corporate Services Limited

 

710135

 

As on 30.09.2010

 

Category

Percentage

 

 

Bodies corporate

12.90

Directors or relatives of Directors

87.10

 

 

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Innovation Driven Device

 

PRODUCTION STATUS AS ON (31.03.2010)

 

Particulars

Unit

Licensed and Installed Capacity

Actual Production

Stents

Nos.

500000

--

Cobal Stents

Nos.

--

4796

Legend Stents

Nos.

--

659

 

 

GENERAL INFORMATION

 

Bankers :

  • State Bank of India, Mid Corporate Loan Administration Unit, 3-2-681/1/A. Hyderguda Main Road, Hyderabad – 500029, Andhra Pradesh, India
  • State Bank of India, Overseas branch, Abids, Hyderabad, India
  • HDFC Bank

 

 

Facilities :

Secured Loan

31.03.2010

Rs.in million

31.03.2009

Rs.in million

SBI CC A/c

41.109

29.556

Term Loan A/c-I SBI

70.163

88.520

Term Loan A/c-II SBI

47.498

40.127

Term Loan A/c-Vehicles SBI

1.668

2.134

Term Loan A/c-DBT Soft Loan

68.000

68.000

Term Loan A/c-APSFC

30.000

0.000

HDFC Vehicle Loan

0.000

0.165

Total

258.438

228.502

In relation to Secured loan

State Bank of India, Cash Credit Account :

First charge on stocks, bok debts and other current assets, [personal guarantees of the promoter directors

Second charge on fixed assets Pledge of 719086 shares belonging to the promoterlnon promoter directors at face value of Rs.10/-

Term Loan A/c-I State Bank of India

 i.Pari-passu frst charge (hyp.) on fixed assets along with APSFC

ii) Pari-passu fust charge (EM) of land and building belonging to the compnay in Sec. No.3 11,3 12 the 3 13 admeasuring 7.00 acres in Mangalpally Village, Pocharam Road, IbmhimvatnamN). RR dist along with APSFC

i) Second charge on all stocks, bood debts and other current assets

ii) Pledge of 719086 shares belonging to the promoterlnon promoter directors at face value of Rs.10/-

Term Loan A/c-II State Bank of India  

i.Pari-passu frst charge (hyp.) on fixed assets along with APSFC

ii) Pari-passu fust charge (EM) of land and building belonging to the compnay in Sec. No.3 11,3 12 the 3 13 admeasuring 7.00 acres in Mangalpally Village, Pocharam Road, IbmhimvatnamN). RR dist along with APSFC

i) Second charge on all stocks, bood debts and other current assets

ii) Pledge of 719086 shares belonging to the promoterlnon promoter directors at face value of Rs.10/-

Term Loan A/c-Vehicles SBI

Hypothecation of Vehicles purchased out of loan

Term Loan Department of Bio technology Soft Loan

Hypothecation of assets purchased out of DBT loan

Term Loan A/c-Andhra Pradesh State Finance Corporation   

i.Pari-passu frst charge (hyp.) on fixed assets along with SBI

ii) Pari-passu fust charge (EM) of land and building belonging to the compnay in Sy. No.3 11,3 12 the 3 13 admeasuring 7.00 acres in Mangalpally Village, Pocharam Road, IbmhimvatnamN). RR dist along with SBI

Personal Gurantee of Promoter/non promoter directors

 

 

Unsecured Loan

31.03.2010

Rs.in million

31.03.2009

Rs.in million

Unsecured Loan

62.680

26.264

Security Deposit

6.150

0.650

Total

68.830

26.914

 

 

 

Banking Relations :

--

 

 

Financial Institution :

The Andhra Pradesh State Financial Corporation, Chirag Ali Lane, Hyderabad – 500001, Andhra Pradesh, India

 

 

Auditors :

 

Name :

P. Murali Mohana Rao

Chartered Accountant

Address :

6-3-655/2/3, Somajiguda, Hyderabad - 500082, Andhra Pradesh, India

Tel. No.:

91-40-23326666

PAN No.:

AAWPP7457L

 


 

 

CAPITAL STRUCTURE

 

As on 30.09.2010

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

7,000,000

Equity Shares

Rs.10/-each

Rs.70.000 million

 

 

 

 

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

6,191,730

Equity Shares

Rs.10/-each

Rs.61.917 million

 

 

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

61.917

58.240

45.371

2] Share Premium

198.210

189.391

154.458

3] Reserves & Surplus

7.968

8.294

2.891

4] Share Application Money

0.000

3.314

0.000

NETWORTH

268.095

259.239

202.720

LOAN FUNDS

 

 

 

1] Secured Loans

258.438

228.502

137.005

2] Unsecured Loans

68.830

26.914

10.880

TOTAL BORROWING

327.268

255.416

147.885

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

595.363

514.655

350.605

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

324.637

280.515

217.978

Capital work-in-progress

182.588

112.906

58.276

 

 

 

 

INVESTMENT

0.006

0.006

0.006

DEFERREX TAX ASSETS

1.262

3.381

(2.633)

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

87.399

96.224

50.714

 

Sundry Debtors

7.324

19.388

4.076

 

Cash & Bank Balances

0.136

3.660

0.146

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

10.372

9.249

13.910

Total Current Assets

105.231

128.521

68.846

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

4.505

11.644

0.034

 

Other Current Liabilities

31.482

13.502

6.866

 

Provisions

0.625

0.000

0.000

Total Current Liabilities

36.612

25.146

6.900

Net Current Assets

68.619

103.375

61.946

 

 

 

 

MISCELLANEOUS EXPENSES

18.251

14.472

15.032

 

 

 

 

TOTAL

595.363

514.655

350.605

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2010

31.03.2009

31.03.2008

 

SALES

 

 

 

 

 

Income

40.285

31.085

11.664

 

 

Other Income

0.423

0.930

0.390

 

 

TOTAL                                     (A)

40.708

32.015

12.054

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Goods Sold

24.323

6.982

6.876

 

 

Manufacturing Cost

3.010

5.993

0.000

 

 

Selling and Distribution Expenses

1.017

0.815

0.110

 

 

Misc. Exp. Written Off

0.000

1.608

0.237

 

 

TOTAL                                     (B)

28.350

15.398

7.223

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

12.358

16.617

4.832

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

5.551

3.891

0.000

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

6.807

12.726

4.831

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

4.687

10.801

3.820

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

2.120

1.925

1.011

 

 

 

 

 

Less

TAX                                                                  (I)

0.328

0.217

0.090

 

 

 

 

 

 

PROFIT AFTER TAX (G-I)                                  (J)

1.792

1.708

0.921

 

 

 

 

 

 

DEFERRED INCOMETAX LIABILITY PROVISION

(2.118)

6.014

(3.761)

 

 

 

 

 

 

PROFIT/LOSS AFTER DEFERRED TAX

(0.326)

7.722

(2.840)

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

8.294

2.891

5.865

 

 

 

 

 

 

Provision for FBT

0.000

0.230

0.134

 

 

 

 

 

 

Prior Period Adjustments

0.000

2.089

0.000

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

7.968

8.294

2.891

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export of Goods

19.669

0.548

0.343

 

TOTAL EARNINGS

19.669

0.548

0.343

 

 

 

 

 

 

Earnings Per Share (Rs.)

0.29

0.29

--

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.2008

PAT / Total Income

(%)

4.40

5.33

7.64

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

5.26

6.19

8.67

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

0.49

0.47

0.35

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.01

0.01

0.00

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.36

1.08

0.76

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.87

5.11

9.98

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Note : Registered office address of the company has been shifted from Flat no.408, Air Bus Apartments, Himayatnagar, Hyderabad, - 500029, Andhra Pradesh, India to the present address w.e.f. 20.02.2006

 

Review Of Operations For The Year

 

1. The Company's Manufacturing Facility was commissioned in full scale.

               

2. During the year the company has infused fresh equity of Rs 125 Millions

 

3. The company has signed a non-binding term sheet with US based venture capitalist M/s Caduceus Asia Mauritius Limited (ORBIMED) for an investment of Rs. 250 millions to enable meet the expansion plans like increased working capital requirements, regulatory affairs and clinical trails etc.

 

4. During the year the company has procured and commissioned sophisticated equipments like Laser Cutting Equipment for Peripheral Stents application and ETO Sterilizer (as per USFDA norms) and various production and laboratory equipment like PTCA balloon manufacturing facility, SEM Analytical Microscope, Catheter Extruder and High End Microscopes made fully operational.

 

a. In the current financial year, the company has strengthened the domestic sales and marketing force.

 

b. The company has applied for conversion of OBL CE Certification to OEM CE certification for Cobalt+CE Mounted Stent.

 

c. The company has completed CE dossiers for Cobalt+C , Legend V and Dx catheter and will be shortly filing for CE marking. The company already obtained IS0 certification for the facility and the entire range of products.

 

d. The company has developed Rapomycin coated stents and the product currently undergoing invitro evaluation.

 

e. The Company has executed export order worth 3,95,160 USD for supply of Cobalt+CE stents to MIS. Limit Medikal Limited,Turky and is expected to execute supply of 5000 Stents per annum to the same customer during the Financial Year 2010-1 1.

 

f. The company has signed Annual supply contract worth of Rs. 65 Millions with M/s Eurocor Singapore Pte Limited( Subsidiary of Mls.Opto Circuits Limited) for supply of 15000 Cobalt chromium Stent systems and 5000 PTCA Balloon Catheters and will be executed during the financial year 2010-1 1.

 

g. The Company is in the process of entering into MOU with some of the renowned Medical Devices Distributors in Europe as its authorized Distributors for the Entire range of Relisys Products in various European countries.

 

h. With the above developments, the turnover of the company is likely to grow manifold in domestic and international markets during the current financial year.

 

FIXED ASSETS :

 

  • Land
  • Furniture and Fixture
  • Lab Equipment
  • Plant and Machinery
  • Office Equipment
  • Computers
  • Vehicle
  • Building
  • Electrical Installations

 

Bankers Charges Report as per Registry

 

Corporate identity number of the company

U85101AP1997PLC028153

Name of the company

RELISYS MEDICAL DEVICES LIMITED

Address of the registered office or of the principal place of  business in India of the company

Sy No.312, Pocharam Road, Mangalapally Village, Ibrahimpatnam, Andhra Pradesh – 501510, India

This form is for

Creation of Charge

Type of charge

Movable Property (not being pledge)

Particular of charge holder

Department of BNoi technology, Block 2, CGO Complex, Lodhi Road, New Delhi – 110003, Delhi, India

Email : sninawe@dbt.nic.in

Nature of instrument creating charge

Deed of Hypothecation dated 22nd July, 2009

Date of instrument Creating the charge

22.07.2009

Amount secured by the charge

Rs.80.000 million

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest - Upto Rs.100 Lakhs : 1%

More than Rs.100 Lakhs : 2%

 

Terms of Repayment - Repayable in 10 equal yearly installments starting six months after completion of the project.

 

Margin - 36.33%

 

Extent and Operation of the charge - Whole of the movable and immovable properties acquired from the loan sanctioned by the Department of Biotechnology (DBT) under the SBIRI scheme including its movable plant and machinery, machinery spares, tools and accessories and other movables both present and future (save and except book debts)s

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Whole of the movable and immovable properties acquired from the loan sanctioned by the Department of Biotechnology (DBT) under the SBIRI scheme.

The above movable and immovable properties includes movable plant and machinery, machinery spares, tools and accessories and other movables both present and future (save and except book debts)

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.44.96

UK Pound

1

Rs.73.56

Euro

1

Rs.63.68

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

2

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

3

--RESERVES

1~10

2

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

30

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.